BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 21971147)

  • 1. [Intrahepatic portosystemic venous shunt via right renal vein successfully treated with balloon-occluded retrograde transvenous obliteration].
    Hashiguchi K; Yamasaki K; Ichikawa T; Takeshima F; Nakao K
    Nihon Shokakibyo Gakkai Zasshi; 2011 Oct; 108(10):1726-34. PubMed ID: 21971147
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [A case of portal-systemic shunt-through inferior mesenteric vein and right internal iliac vein-encephalopathy cured by balloon-occluded retrograde transvenous obliteration].
    Shimizu K; Nakashima M; Fujimoto M; Tsuruta S; Morita S; Furukawa R; Mori M
    Nihon Shokakibyo Gakkai Zasshi; 2009 Dec; 106(12):1764-9. PubMed ID: 19966519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful portal-systemic shunt occlusion with balloon-occluded retrograde transvenous obliteration for portosystemic encephalopathy without liver cirrhosis.
    Tanaka O; Ishihara K; Oyamada H; Harusato A; Yamaguchi T; Ozawa M; Nakano K; Yamagami T; Nishimura T
    J Vasc Interv Radiol; 2006 Dec; 17(12):1951-5. PubMed ID: 17185692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intraperitoneal bleeding after balloon-occluded retrograde transvenous obliteration: a case report.
    Furue Y; Hidaka H; Fujii K; Matsunaga K; Koizumi W
    J Med Case Rep; 2015 Mar; 9():62. PubMed ID: 25886049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Successful balloon-occluded retrograde transvenous obliteration (B-RTO) in a case of symptomatic epilepsy with hepatic encephalopathy due to non-cirrhotic porto-systemic shunt].
    Shibata A; Hayashi S; Noguchi M
    Rinsho Shinkeigaku; 2005 May; 45(5):341-5. PubMed ID: 15960169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic encephalopathy secondary to intrahepatic portosystemic venous shunt: balloon-occluded retrograde transvenous embolization with n-butyl cyanoacrylate and microcoils.
    Yamagami T; Nakamura T; Iida S; Kato T; Tanaka O; Matsushima S; Ito H; Okuyama C; Ushijima Y; Shiga K; Nishimura T
    Cardiovasc Intervent Radiol; 2002; 25(3):219-21. PubMed ID: 12058220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of balloon-occluded retrograde transvenous obliteration (B-RTO) performed in a patient with primary biliary cirrhosis with severe recurrent hepatic encephalopathy due to splenorenal shunt.
    Takashimizu S; Watanabe N; Kojima S; Kagawa T; Mine T; Myojin K; Koizumi J
    Tokai J Exp Clin Med; 2007 Jul; 32(2):70-4. PubMed ID: 21319062
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension.
    Miyamoto Y; Oho K; Kumamoto M; Toyonaga A; Sata M
    J Gastroenterol Hepatol; 2003 Aug; 18(8):934-42. PubMed ID: 12859723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Successful portal-systemic shunt occlusion of a direct shunt between the inferior mesenteric vein and inferior vena cava with balloon-occluded retrograde transvenous obliteration following recanalization after placing a covered stent in the portal and superior mesenteric veins.
    Hayashi S; Baba Y; Senokuchi T; Ueno K; Nakajo M
    Jpn J Radiol; 2009 May; 27(4):180-4. PubMed ID: 19499309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Portal-systemic shunt between the inferior mesenteric vein and inferior vena cava in a patient with hepatic encephalopathy: successful occlusion by balloon-occluded retrograde transvenous obliteration.
    Kakizawa H; Toyota N; Hieda M; Ishikawa M; Tanitame K; Tani C; Okazaki A; Takaki S; Aikata H; Chayama K; Awai K
    Hiroshima J Med Sci; 2011 Mar; 60(1):15-9. PubMed ID: 21675043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Control of solitary gastric fundal varices and portosystemic encephalopathy accompanying liver cirrhosis by balloon-occluded retrograde transvenous obliteration (B-RTO): a case report.
    Ohmoto K; Miyake I; Tsuduki M; Ohno S; Yamamoto S
    Hepatogastroenterology; 1999; 46(26):1249-52. PubMed ID: 10370701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An Adult Case of Congenital Extrahepatic Portosystemic Shunt Successfully Treated with Balloon-occluded Retrograde Transvenous Obliteration.
    Tanaka H; Saijo Y; Tomonari T; Tanaka T; Taniguchi T; Yagi S; Okamoto K; Miyamoto H; Sogabe M; Sato Y; Muguruma N; Tsuneyama K; Sata M; Takayama T
    Intern Med; 2021 Jun; 60(12):1839-1845. PubMed ID: 33456037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of portosystemic shunt-borne hepatic encephalopathy in a 97-year-old woman using balloon-occluded retrograde transvenous obliteration: A case report.
    Nishi A; Kenzaka T; Sogi M; Nakaminato S; Suzuki T
    World J Clin Cases; 2023 Feb; 11(4):945-951. PubMed ID: 36818635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome.
    Kumamoto M; Toyonaga A; Inoue H; Miyakoda K; Morita Y; Emori K; Sakamoto Y; Oho K; Sata M
    J Gastroenterol Hepatol; 2010 Jun; 25(6):1129-35. PubMed ID: 20594229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Balloon-occluded retrograde transvenous obliteration of varices: focusing on the portal hemodynamics and the recent techniques.
    Hirota S; Kobayashi K; Kako Y; Takaki H; Yamakado K
    Hepatol Int; 2018 Feb; 12(Suppl 1):102-111. PubMed ID: 28875380
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful embolization of an intrahepatic portosystemic shunt using balloon-occluded retrograde transvenous obliteration: A case report.
    Saito H; Murata S; Sugihara F; Ueda T; Yasui D; Miki I; Hayashi H; Kumita SI
    World J Clin Cases; 2022 Feb; 10(6):2023-2029. PubMed ID: 35317161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long term results of balloon-occluded retrograde transvenous obliteration for portosystemic shunt encephalopathy in patients with liver cirrhosis and portal hypertension.
    Inoue H; Emori K; Toyonaga A; Oho K; Kumamoto M; Haruta T; Mitsuyama K; Tsuruta O; Sata M
    Kurume Med J; 2014; 61(1-2):1-8. PubMed ID: 25420513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Balloon-occluded retrograde transvenous obliteration (BRTO) for a direct shunt between the inferior mesenteric vein and the inferior vena cava in a patient with hepatic encephalopathy.
    Ibukuro K; Sugihara T; Tanaka R; Fukuda H; Abe S; Tobe K; Tateishi R; Tagawa K
    J Vasc Interv Radiol; 2007 Jan; 18(1 Pt 1):121-5. PubMed ID: 17296712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Balloon occlusion retrograde transvenous obliteration for inferior mesenteric vein-systemic shunt.
    Minamiguchi H; Kawai N; Sato M; Ikoma A; Sawa M; Sonomura T; Sahara S; Nakata K; Tanaka T; Takasaka I; Nakai M
    J Vasc Interv Radiol; 2011 Jul; 22(7):1039-44. PubMed ID: 21708323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis.
    Kato T; Uematsu T; Nishigaki Y; Sugihara J; Tomita E; Moriwaki H
    Intern Med; 2001 Aug; 40(8):688-91. PubMed ID: 11518103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.